Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 121

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis

Hubert, Dominique, Réglier-Poupet, Hélène, Sermet-Gaudelus, Isabelle, Ferroni, Agnès, Le Bourgeois, Muriel, Burgel, Pierre-Régis, Serreau, Raphaël, Dusser, Daniel, Poyart, Claire, Coste, Joël·2013·Journal of Cystic Fibrosis

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcf.2012.12.003

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 21

  1. Goss, 2011, Staphylococcus aureus and MRSA in cystic fibrosis, J Cyst Fibros, 10, 298, 10.1016/j.jcf.2011.06.002 · DOI · Paper page
  2. Kahl, 2010, Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung disease, Int J Med Microbiol, 300, 514, 10.1016/j.ijmm.2010.08.002 · DOI
  3. Stone, 2007, Update on the epidemiology and management of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, in patients with cystic fibrosis, Curr Opin Pulm Med, 13, 515, 10.1097/MCP.0b013e3282efbbac · DOI
  4. Dasenbrook, 2011, Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis, Curr Opin Pulm Med, 17, 437, 10.1097/MCP.0b013e32834b95ed · DOI
  5. Emerson, 2002, Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis, Pediatr Pulmonol, 34, 91, 10.1002/ppul.10127 · DOI · Paper page
  6. Courtney, 2007, Predictors of mortality in adults with cystic fibrosis, Pediatr Pulmonol, 42, 525, 10.1002/ppul.20619 · DOI · Paper page
  7. Gibson, 2003, Pathophysiology and management of pulmonary infections in cystic fibrosis, Am J Respir Crit Care Med, 168, 918, 10.1164/rccm.200304-505SO · DOI · Paper page
  8. Ren, 2007, Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function, Pediatr Pulmonol, 42, 513, 10.1002/ppul.20604 · DOI
  9. Dasenbrook, 2008, Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis, Am J Respir Crit Care Med, 178, 814, 10.1164/rccm.200802-327OC · DOI · Paper page
  10. Dasenbrook, 2010, Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis, JAMA, 303, 2386, 10.1001/jama.2010.791 · DOI · Paper page
  11. Hauser, 2011, Clinical significance of microbial infection and adaptation in cystic fibrosis, Clin Microbiol Rev, 24, 29, 10.1128/CMR.00036-10 · DOI · Paper page
  12. Burns, 1998, Microbiology of sputum from patients at cystic fibrosis centers in the United States, Clin Infect Dis, 27, 158, 10.1086/514631 · DOI · Paper page
  13. Muhlebach, 2011, Treatment intensity and characteristics of MRSA infection in cystic fibrosis, J Cyst Fibros, 10, 201, 10.1016/j.jcf.2011.02.004 · doi:10.1016/j.jcf.2011.02.004
  14. Huang, 1987, Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis, Am J Med, 82, 871, 10.1016/0002-9343(87)90147-1 · DOI
  15. Liou, 2001, Predictive 5-year survivorship model of cystic fibrosis, Am J Epidemiol, 153, 345, 10.1093/aje/153.4.345 · DOI · Paper page
  16. Navarro, 2001, Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF, Eur Respir J, 18, 298, 10.1183/09031936.01.00068901 · DOI · Paper page
  17. Vanderhelst, 2012, Prevalence and impact on FEV1 decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients, J Cyst Fibros, 11, 2, 10.1016/j.jcf.2011.08.006 · DOI
  18. Sawicki, 2008, The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis, Pediatr Pulmonol, 43, 1117, 10.1002/ppul.20914 · DOI
  19. Rosenbluth, 2004, Lung function decline in cystic fibrosis patients and timing for lung transplantation referral, Chest, 126, 412, 10.1378/chest.126.2.412 · DOI
  20. Hudson, 1993, Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years, J Pediatr, 122, 854, 10.1016/S0022-3476(09)90007-5 · DOI
  21. Sagel, 2009, Impact of Pseudomonas and staphylococcal infection on inflammation and clinical status in young children with cystic fibrosis, J Pediatr, 154, 183, 10.1016/j.jpeds.2008.08.001 · DOI · Paper page

Cited by

See all 121

Metadata

Authors
Hubert, D., Réglier-Poupet, H., Sermet-Gaudelus, I., Ferroni, A., Le Bourgeois, M., Burgel, P.-R., Serreau, R., Dusser, D., Poyart, C., & Coste, J.
Venue
Journal of Cystic Fibrosis
Publisher
Elsevier BV
Published
2013-09
Volume
12
Issue
5
Pages
497-503
ISSN
1569-1993
Cited by
121
References
1
Language
en
Licence
Funders
French CF Association Vaincre la Mucoviscidose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis. https://app.cochat.ai/papers/10.1016/j.jcf.2012.12.003
The paper
Hubert, D., Réglier-Poupet, H., Sermet-Gaudelus, I., Ferroni, A., Le Bourgeois, M., Burgel, P.-R., Serreau, R., Dusser, D., Poyart, C., & Coste, J. (2013). Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2012.12.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.